These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35896732)

  • 41. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 42. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas.
    Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB
    J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
    Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
    Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
    Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
    Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
    Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
    Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
    Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
    BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
    Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
    Front Immunol; 2021; 12():783362. PubMed ID: 35154072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes.
    Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Jiang S; Zhang W; Zhong C
    Sci Rep; 2022 Aug; 12(1):13766. PubMed ID: 35962042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.
    Sun Z; Sun X; Yuan Y; Li H; Li X; Yao Z
    Medicine (Baltimore); 2023 Sep; 102(37):e35084. PubMed ID: 37713871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
    Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
    Front Immunol; 2022; 13():903758. PubMed ID: 36016939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 56. Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes.
    Han K; Wang J; Qian K; Zhao T; Liu X; Zhang Y
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.
    Li M; Xu T; Yang R; Wang X; Zhang J; Wu S
    BMC Cancer; 2024 Oct; 24(1):1258. PubMed ID: 39390460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma.
    Wang Z; Zhang Y; Chen Y; Liu S; Li C; Li X
    Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):181-191. PubMed ID: 35026122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel immune-related prognostic index for predicting breast cancer overall survival.
    Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
    Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.